| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |